{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:26:12Z","timestamp":1738473972317,"version":"3.35.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12325-024-03090-7","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T09:10:27Z","timestamp":1735809027000},"page":"1283-1289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus Medications"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-8182","authenticated-orcid":false,"given":"Jasmine","family":"Ion Titapiccolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-829X","authenticated-orcid":false,"given":"Thilo","family":"Schaufler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Jurgen","family":"Arens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Len","family":"Usvyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Stuard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Soro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"3090_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11136-023-03438-6","volume":"2023","author":"JI Titapiccolo","year":"2023","unstructured":"Titapiccolo JI, Lonati C, Goethel-Paal B, et al. Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients. Qual Life Res. 2023;2023:1\u201312. https:\/\/doi.org\/10.1007\/S11136-023-03438-6.","journal-title":"Qual Life Res"},{"issue":"21","key":"3090_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000010633","volume":"97","author":"X Hu","year":"2018","unstructured":"Hu X, Sang Y, Yang M, Chen X, Tang W. Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients: a meta-analysis of cross-sectional studies. Medicine (Baltimore). 2018;97(21):e10633. https:\/\/doi.org\/10.1097\/md.0000000000010633.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"3090_CR3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/J.JAAD.2017.08.025","volume":"77","author":"TA Kouwenhoven","year":"2017","unstructured":"Kouwenhoven TA, van de Kerkhof PCM, Kamsteeg M. Use of oral antidepressants in patients with chronic pruritus: a systematic review. J Am Acad Dermatol. 2017;77(6):1068-1073.e7. https:\/\/doi.org\/10.1016\/J.JAAD.2017.08.025.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3090_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","volume":"70","author":"E Simonsen","year":"2017","unstructured":"Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis. 2017;70(5):638\u201355. https:\/\/doi.org\/10.1053\/j.ajkd.2017.05.018.","journal-title":"Am J Kidney Dis"},{"key":"3090_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04424-w","author":"S-J Guo","year":"2024","unstructured":"Guo S-J, Shi Y-Q, Zheng Y-N, Liu H, Zheng Y-L. The voltage-gated calcium channel \u03b12\u03b4 subunit in neuropathic pain. Mol Neurobiol. 2024. https:\/\/doi.org\/10.1007\/s12035-024-04424-w.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3090_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1159\/000518391","volume":"46","author":"M Makar","year":"2021","unstructured":"Makar M, Smyth B, Brennan F. Chronic kidney disease-associated pruritus: a review. Kidney Blood Press Res. 2021;46(6):659\u201369. https:\/\/doi.org\/10.1159\/000518391.","journal-title":"Kidney Blood Press Res"},{"issue":"Suppl 3","key":"3090_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/CKJ\/SFAB167","volume":"14","author":"ZM Lipman","year":"2021","unstructured":"Lipman ZM, Paramasivam V, Yosipovitch G, Germain MJ. Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches. Clin Kidney J. 2021;14(Suppl 3):i16. https:\/\/doi.org\/10.1093\/CKJ\/SFAB167.","journal-title":"Clin Kidney J"},{"key":"3090_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ekir.2023.04.003","volume":"8","author":"JO Burton","year":"2023","unstructured":"Burton JO, Walpen S, Danel S, Schr\u00f6ppel B, Burton J. Current practices in CKD-associated pruritus: international nephrologist survey. Kidney Int Reports. 2023;8:1455\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2023.04.003.","journal-title":"Kidney Int Reports"},{"key":"3090_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000446056","volume":"50","author":"T Mettang","year":"2016","unstructured":"Mettang T. Uremic itch management. Curr Probl Dermatol. 2016;50:133\u201341. https:\/\/doi.org\/10.1159\/000446056.","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"3090_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.18773\/AUSTPRESCR.2020.004","volume":"43","author":"K Li","year":"2020","unstructured":"Li K, Brown M. Prescribing in renal supportive care. Aust Prescr. 2020;43(2):57\u201360. https:\/\/doi.org\/10.18773\/AUSTPRESCR.2020.004.","journal-title":"Aust Prescr"},{"issue":"8","key":"3090_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xkme.2022.100512","volume":"4","author":"J Topf","year":"2022","unstructured":"Topf J, Wooldridge T, McCafferty K, et al. Efficacy of difelikefalin for the treatment of moderate to severe pruritus in hemodialysis patients: pooled analysis of KALM-1 and KALM-2 phase\u00a03 studies. Kidney Med. 2022;4(8):1\u201311. https:\/\/doi.org\/10.1016\/j.xkme.2022.100512.","journal-title":"Kidney Med"},{"issue":"2","key":"3090_CR12","doi-asserted-by":"publisher","first-page":"AB5","DOI":"10.1016\/j.jaci.2023.11.041","volume":"153","author":"L Beck","year":"2024","unstructured":"Beck L, et al. Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from a 5-year open-label extension trial. J Allergy Clin Immunol. 2024;153(2):AB5. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.041.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3090_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13671-017-0204-7","volume":"6","author":"A Reich","year":"2017","unstructured":"Reich A, Szcz\u0119ch J, Samotij D. Biologics for Itch: IL-4\/IL-13, IL-31, IL-17, and IL-23 antagonists. Curr Dermatol Rep. 2017;6(4):263\u201372. https:\/\/doi.org\/10.1007\/s13671-017-0204-7.","journal-title":"Curr Dermatol Rep"},{"issue":"17","key":"3090_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/nejmoa2301333","volume":"389","author":"SG Kwatra","year":"2023","unstructured":"Kwatra SG, Yosipovitch G, Legat FJ, et al. Phase\u00a03 trial of nemolizumab in patients with prurigo nodularis. N Engl J Med. 2023;389(17):1579\u201389. https:\/\/doi.org\/10.1056\/nejmoa2301333.","journal-title":"N Engl J Med"},{"issue":"8","key":"3090_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10157-021-02047-2","volume":"25","author":"E Kinugasa","year":"2021","unstructured":"Kinugasa E, Igawa K, Shimada H, et al. Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase\u00a0II, randomized, double-blind, placebo-controlled clinical study. Clin Exp Nephrol. 2021;25(8):875\u201384. https:\/\/doi.org\/10.1007\/s10157-021-02047-2.","journal-title":"Clin Exp Nephrol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-03090-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:53:14Z","timestamp":1738407194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-03090-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3090"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-03090-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jasmine Ion Titapiccolo, Luca Neri, Hans-Juergen Arens, Len Usvyat, Stefano Stuard are employees of Fresenius Medical Care. Marco Soro and Thilo Schaufler are employees of CSL Vifor and have CSL share options. Hans-Juergen Arens has share options\/ownership in Fresenius Medical Care, Abbott Laboratories, and AbbVie Inc. Len Usvyat has share options\/ownership in Fresenius Medical Care and he is inventor of patents in the field of dialysis. Len Usvyat is an advisory board member for Privacy Analytics Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All the patients consented to their data being used for secondary data analysis and research. Ethical approval was waived by the Ethics Committee of the Hospital Clinic of Barcelona, Spain with the protocol number Reg. HCB\/2022\/0586. All research was performed in accordance with relevant guidelines and regulations and in particular in accordance with the World Medical Association Declaration of Helsinki regarding the ethical principles for medical research involving human subjects. Patients were involved in the initial design of the study through feedback gathered in patient-reported outcomes from previous quality of life assessments. Additionally, the results of this study will be shared with the patient community through appropriate channels to inform them of the findings and potential implications for future treatment strategies. We are committed to patient-centered research while always safeguarding patient confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}